Breaking News
Get 55% Off 0
🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAY
CLAIM SALE
Close

Nippon India Pharma Fund - Direct Plan - Growth Plan (0P0000XVFK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
569.637 +0.310    +0.05%
08/11 - Closed. Currency in INR
Type:  Fund
Market:  India
Issuer:  Reliance Nippon Life Asset Management Ltd
ISIN:  INF204K01I50 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 86.89B
Reliance Pharma Fund - Direct Plan - Growth Plan 569.637 +0.310 +0.05%

0P0000XVFK Overview

 
Find basic information about the Nippon India Pharma Fund - Direct Plan - Growth Plan mutual fund such as total assets, risk rating, Min. investment, market cap and category. Learn about the fund's agencies rating and risk rating, transparent information about the fund's management personal, policies of invested allocation and diversification, past performance. In addition we provide you related news, analysis tools, interactive charts and analysis articles. You may add 0P0000XVFK MF to your portfolio and watchlist to keep track with the fund's performance and users commentary.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Rating
1-Year Change44.85%
Prev. Close569.331
Risk Rating
TTM Yield0%
ROE18.42%
IssuerReliance Nippon Life Asset Management Ltd
Turnover14%
ROA11.93%
Inception DateJan 01, 2013
Total Assets86.89B
Expenses0.91%
Min. Investment5,000
Market Cap733.63B
CategorySector - Healthcare
What is your sentiment on Reliance Pharma Fund - Direct Plan - Growth Plan?
or
Market is currently closed. Voting is open during market hours.

Nippon India Pharma Fund - Direct Plan - Growth Plan Analysis


Performance

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

YTD 3M 1Y 3Y 5Y 10Y
Growth of 1000 1319 1054 1525 1768 3628 4621
Fund Return 31.89% 5.42% 52.48% 20.92% 29.4% 16.54%
Place in category - - - - - -
% in Category - - - - - -

Top Equity Funds by Nippon Life India Asset Management Ltd

  Name Rating Total Assets YTD% 3Y% 10Y%
  Reliance Small Cap Fund Bonus 622.6B 27.57 29.87 22.79
  Reliance Small Cap Fund Dividend 622.6B 26.66 31.00 23.10
  Reliance Small Cap Fund Growth 622.6B 31.50 30.95 23.53
  Reliance Small Cap Fund Dir Bon 622.6B 28.41 30.99 23.96
  Reliance Small Cap Fund Dir Gr 622.6B 27.71 32.10 24.28

Top Funds for Sector - Healthcare Category

  Name Rating Total Assets YTD% 3Y% 10Y%
  Reliance Pharma Fund - Bonus 87.69B 32.97 19.34 15.71
  Reliance Pharma Dividend Payout 87.69B 31.99 20.76 16.77
  Reliance Pharma Fund - Growth 87.69B 32.97 19.34 15.71
  Reliance Pharma Direct Bonus 87.69B 33.87 20.43 16.73
  Reliance Pharma Dir Div Payout 87.69B 33.32 21.58 17.50

Top Holdings

Name ISIN Weight % Last Change %
  Sun Pharma INE044A01036 14.41 1,809.60 +1.04%
  Divi's Labs INE361B01024 8.39 5,949.85 -0.17%
  Lupin INE326A01037 8.01 2,104.60 -0.33%
  Cipla INE059A01026 5.85 1,592.60 +1.04%
Dr Reddy's Laboratories Ltd INE089A01023 5.39 - -

Technical Summary

Type Daily Weekly Monthly
Moving Averages Buy Buy Buy
Technical Indicators Strong Buy Strong Buy BUY
Summary Strong Buy Strong Buy Buy
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000XVFK Comments

Write your thoughts about Nippon India Pharma Fund - Direct Plan - Growth Plan
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email